CHD1L Regulated PARP1-Driven Pluripotency and Chromatin Remodeling during the Early-Stage Cell Reprogramming

Stem Cells

Volumn 33, Issue 10, 2015, Pages 2961-2972

  Jiang, Bo Hua ^a   Chen, Wei Yi ^a   Li, Hsin Yang ^a   Chien, Yueh ^a,b   Chang, Wei Chao ^c,d   Hsieh, Pei Chen ^a   Wu, Ping ^a,b   Chen, Chieh Yu ^a   Song, Hui Yung ^a   Chien, Chian Shiu ^a,b   Sung, Yen Jen ^a   Chiou, Shih Hwa ^a,b,e  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d ASIA UNIVERSITY   (Taiwan)

^e GENOMICS RESEARCH CENTER   (Taiwan)

Author keywords

CHD1L; Chromatin remodeling; PARP1; PARylation; Reprogramming

Indexed keywords

DNA HELICASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN CHD1L; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ESRRB; TRANSCRIPTION FACTOR NANOG; UNCLASSIFIED DRUG; CHD1L PROTEIN, MOUSE; DNA BINDING PROTEIN; ESRRB PROTEIN, MOUSE; ESTROGEN RECEPTOR; HOMEODOMAIN PROTEIN; NANOG PROTEIN, MOUSE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PARP1 PROTEIN, MOUSE; POU5F1 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL FUNCTION; CHEMICAL MODIFICATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMATIN IMMUNOPRECIPITATION; CHROMATIN STRUCTURE; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; ENZYME ACTIVITY; GENE LOCUS; GENE SILENCING; MOUSE; NONHUMAN; NUCLEAR REPROGRAMMING; PLURIPOTENCY; PLURIPOTENT STEM CELL; POLY(ADP RIBOSYL)ATION; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; UPREGULATION; ANIMAL; BIOSYNTHESIS; CELL DIFFERENTIATION; GENETICS;

ANIMALS; CELL DIFFERENTIATION; CELLULAR REPROGRAMMING; CHROMATIN ASSEMBLY AND DISASSEMBLY; DNA HELICASES; DNA-BINDING PROTEINS; GENE KNOCKDOWN TECHNIQUES; HOMEODOMAIN PROTEINS; MICE; NANOG HOMEOBOX PROTEIN; OCTAMER TRANSCRIPTION FACTOR-3; PLURIPOTENT STEM CELLS; POLY (ADP-RIBOSE) POLYMERASE-1; POLY(ADP-RIBOSE) POLYMERASES; RECEPTORS, ESTROGEN;

EID: 84942323889     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.2116     Document Type: Article

References (36)

1. Ame JC, Spenlehauer C, de Murcia G,. The PARP superfamily. Bioessays 2004; 26: 882-893.
2. Krishnakumar R, Kraus WL,. The PARP side of the nucleus: Molecular actions, physiological outcomes, and clinical targets. Mol Cell 2010; 39: 8-24.
3. Hassa PO, Hottiger MO,. The functional role of poly(ADP-ribose)polymerase 1 as novel coactivator of NF-kappaB in inflammatory disorders. Cell Mol Life Sci 2002; 59: 1534-1553.
4. Simbulan-Rosenthal CM, Rosenthal DS, Luo R, et al., PARP-1 binds E2F-1 independently of its DNA binding and catalytic domains, and acts as a novel coactivator of E2F-1-mediated transcription during re-entry of quiescent cells into S phase. Oncogene 2003; 22: 8460-8471.
5. Guastafierro T, Cecchinelli B, Zampieri M, et al., CCCTC-binding factor activates PARP-1 affecting DNA methylation machinery. J Biol Chem 2008; 283: 21873-21880.
6. Gao F, Kwon SW, Zhao Y, et al., PARP1 poly(ADP-ribosyl)ates Sox2 to control Sox2 protein levels and FGF4 expression during embryonic stem cell differentiation. J Biol Chem 2009; 284: 22263-22273.
7. Lonn P, van der Heide LP, Dahl M, et al., PARP-1 attenuates Smad-mediated transcription. Mol Cell 2010; 40: 521-532.
8. Lai YS, Chang CW, Pawlik KM, et al., SRY (sex determining region Y)-box2 (Sox2)/poly ADP-ribose polymerase 1 (Parp1) complexes regulate pluripotency. Proc Natl Acad Sci USA 2012; 109: 3772-3777.
9. Weber FA, Bartolomei G, Hottiger MO, et al., Artd1/Parp1 regulates reprogramming by transcriptional regulation of Fgf4 via Sox2 ADP-ribosylation. Stem Cells 2013; 31: 2364-2373.
10. Krishnakumar R, Kraus WL,. PARP-1 regulates chromatin structure and transcription through a KDM5B-dependent pathway. Mol Cell 2010; 39: 736-749.
11. Doege CA, Inoue K, Yamashita T, et al., Early-stage epigenetic modification during somatic cell reprogramming by Parp1 and Tet2. Nature 2012; 488: 652-655.
12. Efroni S, Duttagupta R, Cheng J, et al., Global transcription in pluripotent embryonic stem cells. Cell Stem Cell 2008; 2: 437-447.
13. Bian Y, Alberio R, Allegrucci C, et al., Epigenetic marks in somatic chromatin are remodelled to resemble pluripotent nuclei by amphibian oocyte extracts. Epigenetics 2009; 4: 194-202.
14. Gaspar-Maia A, Alajem A, Polesso F, et al., Chd1 regulates open chromatin and pluripotency of embryonic stem cells. Nature 2009; 460: 863-868.
15. Meissner A,. Epigenetic modifications in pluripotent and differentiated cells. Nat Biotechnol 2010; 28: 1079-1088.
16. Mattout A, Meshorer E,. Chromatin plasticity and genome organization in pluripotent embryonic stem cells. Curr Opin Cell Biol 2010; 22: 334-341.
17. Mattout A, Meshorer E,. Chromatin plasticity and genome organization in pluripotent embryonic stem cells. Curr Opin Cell Biol 2010; 22: 334-341.
18. Singhal N, Graumann J, Wu G, et al., Chromatin-remodeling components of the BAF complex facilitate reprogramming. Cell 2010; 141: 943-955.
19. Orkin SH, Hochedlinger K,. Chromatin connections to pluripotency and cellular reprogramming. Cell 2011; 145: 835-850.
20. Gaspar-Maia A, Alajem A, Meshorer E, et al., Open chromatin in pluripotency and reprogramming. Nat Rev Mol Cell Biol 2011; 12: 36-47.
21. Apostolou E, Hochedlinger K,. Chromatin dynamics during cellular reprogramming. Nature 2013; 502: 462-471.
22. Ahel D, Horejsi Z, Wiechens N, et al., Poly(ADP-ribose)-dependent regulation of DNA repair by the chromatin remodeling enzyme ALC1. Science 2009; 325: 1240-1243.
23. Gottschalk AJ, Timinszky G, Kong SE, et al., Poly(ADP-ribosyl)ation directs recruitment and activation of an ATP-dependent chromatin remodeler. Proc Natl Acad Sci USA 2009; 106: 13770-13774.
24. Snider AC, Leong D, Wang QT, et al., The chromatin remodeling factor Chd1l is required in the preimplantation embryo. Biol Open 2013; 2: 121-131.
25. Ma NF, Hu L, Fung JM, et al., Isolation and characterization of a novel oncogene, amplified in liver cancer 1, within a commonly amplified region at 1q21 in hepatocellular carcinoma. Hepatology 2008; 47: 503-510.
26. Kim MY, Mauro S, Gevry N, et al., NAD+-dependent modulation of chromatin structure and transcription by nucleosome binding properties of PARP-1. Cell 2004; 119: 803-814.
27. Chiou SH, Jiang BH, Yu YL, et al., Poly(ADP-ribose) polymerase 1 regulates nuclear reprogramming and promotes iPSC generation without c-Myc. J Exp Med 2013; 210: 85-98.
28. Gottschalk AJ, Trivedi RD, Conaway JW, et al., Activation of the SNF2 Family ATPase ALC1 by Poly(ADP-ribose) in a Stable ALC1{middle dot}PARP1{middle dot}Nucleosome Intermediate. J Biol Chem 2012; 287: 43527-43532.
29. Takahashi K, Yamanaka S,. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663-676.
30. Koche RP, Smith ZD, Adli M, et al., Reprogramming factor expression initiates widespread targeted chromatin remodeling. Cell Stem Cell 2011; 8: 96-105.
31. Narlikar GJ, Sundaramoorthy R, Owen-Hughes T,. Mechanisms and functions of ATP-dependent chromatin-remodeling enzymes. Cell 2013; 154: 490-503.
32. Lin JJ, Lehmann LW, Bonora G, et al., Mediator coordinates PIC assembly with recruitment of CHD1. Genes Dev 2011; 25: 2198-2209.
33. Pardo M, Lang B, Yu L, et al., An expanded Oct4 interaction network: Implications for stem cell biology, development, and disease. Cell Stem Cell 2010; 6: 382-395.
34. Loh KM, Lim B,. Epigenetics: Actors in the cell reprogramming drama. Nature 2012; 488: 599-600.
35. Watanabe A, Yamada Y, Yamanaka S,. Epigenetic regulation in pluripotent stem cells: A key to breaking the epigenetic barrier. Philos Trans R Soc Lond B Biol Sci 2013; 368: 20120292.
36. Deng W,. PARylation: Strengthening the connection between cancer and pluripotency. Cell Stem Cell 2009; 5: 349-350.